Jianmin Pharmaceutical Group financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥530.23M ¥911.03M ¥1.30B ¥1.04B ¥1.29B ¥1.53B ¥1.57B ¥1.41B ¥1.54B ¥1.99B ¥1.75B ¥2.28B ¥2.36B ¥2.71B ¥2.16B ¥2.24B ¥2.46B ¥3.28B ¥3.64B ¥4.21B ¥0.00M
GM % Gross Margin %
45.37% 21.97% 14.43% 18.18% 16.50% 18.49% 19.97% 23.62% 23.67% 22.23% 25.26% 20.73% 23.87% 27.29% 34.66% 39.76% 40.56% 43.44% 43.23% 45.91% 0.00%
OM Operating Margin
8.48% 3.48% 1.75% 2.57% 1.48% 2.45% 4.17% 5.88% 5.32% 4.58% 5.75% 2.41% 1.66% 1.87% 1.61% 1.91% 2.19% 6.74% 7.22% 7.43% 0.00%
EPS Earnings Per Share
¥0.22 ¥0.33 ¥0.34 ¥0.41 ¥0.66 ¥0.32 ¥2.87 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.30 ¥0.40 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.10 ¥0.20 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥1.20 ¥0.00
PR % Payout Ratio %
0 0 0 0 0 0 90.91% 117.65% 0 0 0 0 31.25% 0 0 0 0 0 0 41.81% 0
Sha. Shares
153.4m 153.4m 153.4m 153.4m 153.4m 153.4m 153.4m 153.03m 153.4m 153.4m 153.4m 153.4m 153.4m 153.4m 153.4m 153.4m 153.4m 151.97m 151.97m 0m 151.97m
OCF Operating Cash Flow
¥4.13M ¥0.00M ¥56.18M ¥-6.88M ¥125.39M ¥66.69M ¥150.08M ¥-75.54M ¥98.17M ¥45.36M ¥103.23M ¥48.45M ¥113.84M ¥35.20M ¥63.60M ¥74.45M ¥125.54M ¥259.18M ¥215.87M ¥268.39M ¥0.00M
FCF Free Cash Flow
¥-53.51M ¥0.00M ¥39.57M ¥-16.79M ¥116.69M ¥52.19M ¥144.67M ¥-83.99M ¥89.20M ¥21.46M ¥76.46M ¥18.70M ¥84.42M ¥-6.73M ¥21.23M ¥5.14M ¥79.96M ¥203.19M ¥147.91M ¥203.89M ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥0.00 ¥0.25 ¥-0.10 ¥0.78 ¥0.34 ¥0.95 ¥-0.55 ¥0.58 ¥0.14 ¥0.50 ¥0.12 ¥0.55 ¥-0.04 ¥0.14 ¥0.03 ¥0.52 ¥1.33 ¥0.97 ¥1.33 ¥0.00